# David A. Rizzieri

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-a-rizzieri/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,134 |
| Field | Acute Myeloid Leukemia Research |
| h-index | 64 |
| i10-index | 244 |
| Last Known Institution | Novant Health |
| OpenAlex ID | https://openalex.org/A5061865992 |
| ORCID iD | https://orcid.org/0000-0001-9886-5771 |
| Works | 582 |

## Researcher papers

- [Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial](https://scholariq.org/papers/disabling-immune-tolerance-by-programmed-death-1-blockade-with-pidilizumab-after/)

## Researcher topics

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Researcher university

- [Novant Health](https://scholariq.org/institutions/novant-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.